Rainbow Children's Medicare Presents Q4 FY26 Audited Financial Results and Investor Presentation
Rainbow Children’s Medicare reported Q4 FY26 audited financial results. Revenue increased by 24% YoY to ₹4,599 million, EBITDA by 26% YoY to ₹1,447 million, and PAT by 38% YoY to ₹782 million. For FY26, revenue was ₹17,031 million (up 12% YoY), EBITDA ₹5,442 million (up 11% YoY), and PAT ₹2,815 million (up 15% YoY). The company also announced the commencement of new facilities in Bengaluru.
The announcement includes detailed financial results and operational KPIs, alongside significant expansion plans and new facility commencements, which are material information for investors and stakeholders.
The company reported strong year-on-year growth in revenue, EBITDA, and PAT for both the quarter and the full fiscal year. The expansion through new facilities and strategic growth plans further contribute to a positive outlook.
Rainbow Children’s Medicare Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. The company has shared an Earnings Presentation detailing these results with analysts and investors. The presentation covers both standalone and consolidated financial performance.
The company's operational performance for Q4 FY26 showed an increase in capacity beds to 27,977 and operational beds to 22,975. In-patient discharges grew by 19% to 424,702, and outpatient consultations increased by 22% to 1,598,970. Occupancy rates stood at 45.3% for Q4 FY26, with an Average Revenue Per Occupied Bed (ARPOB) of ₹2.71 lakh and an Average Length of Stay (ALOS) of 2.71 days.
Financially, for Q4 FY26, the company reported a revenue of ₹4,599 million, a 24% year-on-year increase. EBITDA was ₹1,447 million, up 26% YoY, and Profit After Tax (PAT) was ₹782 million, a 38% YoY increase. For the full fiscal year FY26, revenue stood at ₹17,031 million (up 12% YoY), EBITDA at ₹5,442 million (up 11% YoY), and PAT at ₹2,815 million (up 15% YoY).
Key developments include the commencement of operations for a new 60-bed hospital at HRBR and a dedicated IVF centre at Mahadevapura in Bengaluru. These new facilities are designed as strategic spokes complementing the Marathahalli hub, reinforcing Rainbow's position as the largest pediatric and perinatal care network in Bengaluru with approximately 600 beds across six hospitals, an outpatient clinic, and two fertility centers. The company also outlined its expansion plans, aiming to increase its total bed count to 3,245 by FY28-29 across various cities including Telangana, Bengaluru, Tamil Nadu, NCR, Andhra Pradesh, North East, and Pune.
What to do with a filing like this
Rainbow Childrens Medicare Limited filed this with the NSE as a statutory disclosure, categorised under quarterly results. It is a primary document, not a recommendation, and the desk marks it high impact, which is the band that most often changes something.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Rainbow Childrens Medicare Limited. Read the original for the full detail.